Stop spoon dosing

You grab for the cough syrup for some relief from that nasty lingering cold, what do you measure the dose with? Many of us use teaspoons or table spoons to measure out doses for ourselves and our children but this results in dosage errors. This new study finds that errors in estimating doses can be mitigated by changing the serving measurements on the dosage facts panel from teaspoons to milliliters.

A previous study by authors Koert van Ittersum, PhD at the University of Groningen (The Netherlands) and Brian Wansink, PhD of Cornell University found that when individuals use teaspoons to measure medicine they tend to under-serve by 8.4% and when using table spoons they over-serve by 11.6%.

For this study, Van Ittersum and Wansink proposed that by writing the Drug Facts and dosage information in milliliters, which are more difficult to estimate visually, people would choose more accurate measuring devices to measure out doses and would be less likely to make dosage errors. Of the 177 young adults that participated in this study, 34.5% reported using kitchen spoons most frequently to measure medicine. The researchers found that when these study participants were given dosage information in teaspoons 60.9% chose a teaspoon to measure with while none of them chose the milliliter measuring cup. However, when the dosage recommendation was given in milliliters the teaspoon and the measuring cup were equally popular among this group. These results indicate that the risk of dosage error decreases by around 50% by simply changing the recommended units of measurement from tea spoons to milliliters.

"When measuring medicine for ourselves or our children, we often use regular kitchen spoons but they are not accurate measuring instruments," explains lead author Koert van Ittersum, "While we feel that we can estimate teaspoon doses, milliliters are much harder to estimate visually, therefore people are more likely to use accurate measuring spoons or cups when given dosage information in milliliters."

In conclusion, the authors recommend that the US Food and Drug Administration mandates that the pharmaceutical industry not use teaspoons on Drug Facts and dosing information. They also emphasize the importance of not spoon-dosing at home, instead using the measuring cups that typically come with liquid medicine.

Most Popular Now

In wine, there's health: Low levels of alcohol goo…

While a couple of glasses of wine can help clear the mind after a busy day, new research shows that it may actually help clean the mind as well. The new study, which appe...

Sanofi to acquire Ablynx for €3.9 Billion

Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies®, entered into a definitive agreement under which Sanofi will offer ...

Interim publications of randomized trials make new…

Early results from randomized trials are sometimes published before the trial is completed. The results of such interim publications may generate a great deal of interest...

Drug trial protocol redactions by industry sponsor…

New research published by the Journal of the Royal Society of Medicine exposes the extent of redactions in protocols for industry-sponsored randomised drug trials. Trial ...

Advanced Accelerator Applications receives FDA ap…

Novartis AG (NYSE: NVS) announced that Advanced Accelerator Applications, a subsidiary of Novartis Groupe S.A., has received US Food and Drug Administration (FDA) approva...

Blood vessel-on-a-chips show anti-cancer drug effe…

Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel ...

Brilinta significantly reduces CV events and coron…

AstraZeneca today announced results from a new sub-analysis of the Phase III PEGASUS-TIMI 54 trial, demonstrating a risk reduction of 19% in MACE (the composite of CV dea...

Guidelines extended to improve the use of feedback…

Researchers have recommended changes to international guidelines used in the development of clinical trials in an effort to gain information about the impact of the treat...

Roche reports good results in 2017

In 2017, Group sales rose 5% to CHF 53.3 billion. Core operating profit grew 3% and Core EPS increased 5%, reflecting the good underlying business performance. On an IFRS...

How old antibiotic compounds could become tomorrow…

As the fight against drug-resistant infections continues, University of Leeds scientists are looking back at previously discarded chemical compounds, to see if any could ...

FDA approves new treatment for certain digestive t…

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointesti...

Roche purchases shares in tender offer for Ignyta…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche's wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares v...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]